Cover Image
市場調查報告書

臨床實驗管理系統市場:全球產業分析,規模,市場佔有率,成長,趨勢,及預測

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

出版商 Transparency Market Research 商品編碼 299353
出版日期 內容資訊 英文 113 pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床實驗管理系統市場:全球產業分析,規模,市場佔有率,成長,趨勢,及預測 Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019
出版日期: 2014年04月04日 內容資訊: 英文 113 pages
簡介

臨床實驗管理系統(CTMS)是為了適當管理、保存、分析藥劑相關的臨床實驗資料的解決方案,主要是為了管理與臨床實驗相關的大量數據而引進。醫藥品、生命科學、臨床研究產業研究開發投資的擴大,及罹患率的上升,臨床研究委外的擴展等,推動了該市場的成長。再加上與醫院資訊系統(HIS)和CTMS整合,和文書為主的資訊系統相比,更能在短時間內更正確的管理文書資料。

本報告提供CTMS市場2013∼2019年的詳細分析,以及目前趨勢,彙整各類別,各地區的市場規模,及主要參與企業簡介等資料,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場概要

第4章 市場趨勢

第5章 波特五力分析

第6章 全球市場規模與預測

第7章 按傳送模式市場區隔分析

  • 雲端基礎臨床實驗管理系統
  • 網站基礎的臨床實驗管理系統
  • 內部臨床實驗管理系統

第8章 各終端用戶市場區隔分析

  • 醫藥品產業
  • CRO
  • 醫護人員

第9章 各類型市場區隔分析

  • 企業為基礎的臨床實驗管理系統
  • 網站為基礎的臨床實驗管理系統

第10章 各零件市場區隔分析

  • 軟體
  • 硬體設備
  • 服務

第11章 各地區分析

  • 北美
    • 美國
  • 歐洲
    • 德國
    • 法國
    • 波蘭
  • 亞洲
    • 韓國
    • 中國
  • 其他

第12章 競爭環境

第13章 企業簡介

  • Oracle Corporation
  • Merge Healthcare Inc.
  • Medidata
  • PAREXEL International Corporation
  • BioClinica
  • MedNet Solutions
  • Bio-Optronics
  • DSG
  • eClinForce
  • Forte Research Systems

圖表

目錄

Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. CTMS is primarily employed to manage large amount of data involved in a clinical trial including planning, preparation and reporting. CTMS also provides data to a business intelligence system. Increasing R&D investment in pharmaceuticals, life science and clinical research industries, rising prevalence of diseases and increased clinical research outsourcing are key growth drivers for the CTMS market. In addition, integration of CTMS with a Hospital Information System (HIS) provides more accurate and time saving documentation over paper based information systems.

On the other hand, long approval time for clinical trials and difficulties related to recruiting and enrolling patients for clinical trials are some of the major concerns for the industry. Approval from Institutional Review Board (IRB), contract and budget negotiation and approval, availability of appropriate patient population and protocol design and legal review are major factors that delay a drug approval process. Similarly, increasing regulatory requirements in many countries has resulted in increased complexity for clinical trial protocols.

This report provides an in-depth analysis of estimation of the CTMS market for the period 2013-2019, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and recent developments has been provided in the report. The CTMS market is categorized on the basis of type of CTMS, end users, components, mode of delivery and geography. Based on mode of delivery, the CTMS market comprises on-premise CTMS, Web based CTMS and cloud based CTMS. The end user market comprises pharmaceuticals, clinical research organizations and healthcare providers.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (RoW). North America is further segmented into the U.S. Similarly, Europe is further segmented into Germany, France and Poland. Asia is further segmented into South Korea and China. Some of the major players in the CTMS market are Oracle Corporation, Bio-Optronics, MedNet Solutions, PAREXEL, Medidata Solutions, BioClinica and others. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Research Methodology
    • 1.2.1 Sources
      • 1.2.1.1 Secondary Research
      • 1.2.1.2 Primary Research
      • 1.2.1.3 Assumptions

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Market Trends

Chapter 5 Porters Five Force Analysis

Chapter 6 Global Market Size and Forecast

Chapter 7 Segment Analysis by Delivery Mode

  • 7.1 Cloud Based Clinical Trial Management System
  • 7.2 Web Based Clinical Trial Management System
  • 7.3 On-Premise Clinical Trial Management System

Chapter 8 Segment Analysis by End User

  • 8.1 Pharmaceuticals
  • 8.2 Clinical Research Organizations (CROs)
  • 8.3 Healthcare Providers

Chapter 9 Segment Analysis by Type

  • 9.1 Enterprise Based Clinical Trial Management System
  • 9.2 Site Based Clinical Trial Management System

Chapter 10 Segment Analysis by Components

  • 10.1 Software
  • 10.2 Hardware
  • 10.3 Services

Chapter 11 Regional Analysis

  • 11.1 North America
    • 11.1.1 U.S.
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Poland
  • 11.3 Asia
    • 11.3.1 South Korea
    • 11.3.2 China
  • 11.4 Rest of the world

Chapter 12 Competitive Landscape

Chapter 13 Company Profiles

  • 13.1 Oracle Corporation
    • 13.1.1 Overview
    • 13.1.2 Products & Segments
    • 13.1.3 Financial Performance
    • 13.1.4 Strategic Developments
  • 13.2 Merge Healthcare Inc.
    • 13.2.1 Overview
    • 13.2.2 Products & Segments
    • 13.2.3 Financial Performance
    • 13.2.4 Strategic Developments
  • 13.3 Medidata
    • 13.3.1 Overview
    • 13.3.2 Products & Segments
    • 13.3.3 Financial Performance
    • 13.3.4 Strategic Development
  • 13.4 PAREXEL International Corporation
    • 13.4.1 Overview
    • 13.4.2 Products & Segments
    • 13.4.3 Financial Performance
    • 13.4.4 Strategic Developments
  • 13.5 BioClinica
    • 13.5.1 Overview
    • 13.5.2 Products and Segments
    • 13.5.3 Financial Performance
    • 13.5.4 Strategic Developments
  • 13.6 MedNet Solutions
    • 13.6.1 Overview
    • 13.6.2 Products & Segments
    • 13.6.3 Financial Performance
    • 13.6.4 Strategic Developments
  • 13.7 Bio-Optronics 1
    • 13.7.1 Overview
    • 13.7.2 Products & Segments
    • 13.7.3 Financial Performance
    • 13.7.4 Strategic Developments
  • 13.8 DSG
    • 13.8.1 Overview
    • 13.8.2 Products & Segments
    • 13.8.3 Financial Performance
    • 13.8.4 Strategic Developments
  • 13.9 eClinForce
    • 13.9.1 Overview
    • 13.9.2 Products & Segments
    • 13.9.3 Financial Performance
  • 13.10 Forte Research Systems
    • 13.10.1 Overview
    • 13.10.2 Products & Segments
    • 13.10.3 Financial Performance
    • 13.10.4 Strategic Developments

List of Figures

  • FIG. 1 Applications of clinical trial management system
  • FIG. 2 Process of CTMS
  • FIG. 3 CTMS Market: Porters Five Force Analysis
  • FIG. 4 Global clinical trial management system market, by region 2013E (% share)
  • FIG. 5 Global clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 6 Global clinical trial management system market, by end user 2013E (% share)
  • FIG. 7 Global clinical trial management system market, by type 2013E (% share)
  • FIG. 8 Global clinical trial management system market, by components 2013E (% share)
  • FIG. 9 The North American clinical trial management system market, by country 2013E (% share)
  • FIG. 10 The North American clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 11 The North American clinical trial management system market, by end user 2013E (% share)
  • FIG. 12 The North American clinical trial management system market, by type 2013E (% share)
  • FIG. 13 The North American clinical trial management system market, by component 2013E (% share)
  • FIG. 14 The U.S. clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 15 The U.S. clinical trial management system market, by end user 2013E (% share)
  • FIG. 16 The European clinical trial management system market, by country 2013E (% share)
  • FIG. 17 The European clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 18 The European clinical trial management system market, by end user 2013E (% share)
  • FIG. 19 The European clinical trial management system market, by type 2013E (% share)
  • FIG. 20 The European clinical trial management system market, by component 2013E (% share)
  • FIG. 21 The German clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 22 The German clinical trial management system market, by end user 2013E (% share)
  • FIG. 23 The French clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 24 The French clinical trial management system market, by end user 2013E (% share)
  • FIG. 25 Poland clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 26 Poland clinical trial management system market, by end user 2013E (% share)
  • FIG. 27 The Asian clinical trial management system market, by country 2013E (% share)
  • FIG. 28 The Asian clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 29 The Asian clinical trial management system market, by end user 2013E(% share)
  • FIG. 30 The Asian clinical trial management system market, by type 2013E (% share)
  • FIG. 31 The Asian clinical trial management system market, by component 2013E (% share)
  • FIG. 32 The South Korean clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 33 The South Korean clinical trial management system market, by end user 2013E (% share)
  • FIG. 34 The Chinese clinical trial management system market, by mode of delivery 2013E (% share)
  • FIG. 35 The Chinese clinical trial management system market, by end user 2013E (% share)
  • FIG. 36 Competitive landscape of the global CTMS market
  • FIG. 37 Oracle Corporation total revenue and net income 2011-2013 (USD Million)
  • FIG. 38 Merge Healthcare net sales and net income 2011-2013 (USD Million)
  • FIG. 39 Medidata total revenue and net income 2011-2013 (USD Million)
  • FIG. 40 PAREXEL total service revenue and net income 2011-2013 (USD Million)
  • FIG. 41 BioClinica total revenue and net income 2010-2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: CTMS market (2013 & 2019)
  • TABLE 2 Drivers for CTMS market: Impact analysis
  • TABLE 3 R&D investment in pharmaceutical industry, by country (USD million) in 2010 and 2011
  • TABLE 4 Globally rising prevalence of diabetics, by number of cases (million, 2010 and 2030)
  • TABLE 5 Restraints for CTMS market: Impact analysis
  • TABLE 6 Estimated average timelines for clinical trial approval in various countries
  • TABLE 7 Major collaborations and partnerships by CTMS companies (2011- February 2014)
  • TABLE 8 Some of the major mergers and acquisitions in CTMS market (2011-Februrary 2014)
  • TABLE 9 Global clinical trial management system market size, by region 2009-2012 (USD million)
  • TABLE 10 Global clinical trial management system market size, by region 2013-2019 (USD million)
  • TABLE 11 Global clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 12 Global clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 13 Global clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 14 Global clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 15 Global clinical trial management system market size, by type 2009-2012 (USD million)
  • TABLE 16 Global clinical trial management system market size, by type 2013-2019 (USD million)
  • TABLE 17 Global clinical trial management system market size, by component 2009-2012 (USD million)
  • TABLE 18 Global clinical trial management system market size, by component 2013-2019 (USD million)
  • TABLE 19 The North American clinical trial management market size, by segment 2009-2012 (USD million)
  • TABLE 20 The North American clinical trial management market size, by segment 2013-2019 (USD million)
  • TABLE 21 The North American clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 22 The North American clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 23 The North American clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 24 The North American clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 25 The North American clinical trial management system market size, by type 2009-2012 (USD million)
  • TABLE 26 The North American clinical trial management system market size, by type 2013-2019 (USD million)
  • TABLE 27 The North American clinical trial management system market size, by component 2009-2012 (USD million)
  • TABLE 28 The North American clinical trial management system market size, by component 2013-2019 (USD million)
  • TABLE 29 The U.S. clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 30 The U.S. clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 31 The U.S. clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 32 The U.S. clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 33 The European clinical trial management market size, by segment 2009-2012 (USD million)
  • TABLE 34 The European clinical trial management market size, by segment 2013-2019 (USD million)
  • TABLE 35 The European clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 36 The European clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 37 The European clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 38 The European clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 39 The European clinical trial management system market size, by type 2009-2012 (USD million)
  • TABLE 40 The European clinical trial management system market size, by type 2013-2019 (USD million)
  • TABLE 41 The European clinical trial management system market size, by component 2009-2012 (USD million)
  • TABLE 42 The European clinical trial management system market size, by component 2013-2019 (USD million)
  • TABLE 43 The German clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 44 The German clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 45 The German clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 46 The German clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 47 The French clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 48 The French clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 49 The French clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 50 The French clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 51 Poland clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 52 Poland clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 53 Poland clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 54 Poland clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 55 The Asian clinical trial management market size, by segment 2009-2012 (USD million)
  • TABLE 56 The Asian clinical trial management market size, by segment 2013-2019 (USD million)
  • TABLE 57 The Asian clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 58 The Asian clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 59 The Asian clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 60 The Asian clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 61 The Asian clinical trial management system market size, by type 2009-2012 (USD million)
  • TABLE 62 The Asian clinical trial management system market size, by type 2013-2019 (USD million)
  • TABLE 63 The Asian clinical trial management system market size, by component 2009-2012 (USD million)
  • TABLE 64 The Asian clinical trial management system market size, by component 2013-2019 (USD million)
  • TABLE 65 The South Korean clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 66 The South Korean clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 67 The South Korean clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 68 The South Korean clinical trial management system market size, by end user 2013-2019 (USD million)
  • TABLE 69 The Chinese clinical trial management system market size, by mode of delivery 2009-2012 (USD million)
  • TABLE 70 The Chinese clinical trial management system market size, by mode of delivery 2013-2019 (USD million)
  • TABLE 71 The Chinese clinical trial management system market size, by end user 2009-2012 (USD million)
  • TABLE 72 The Chinese clinical trial management system market size, by end user 2013-2019 (USD million)
Back to Top